NCT01447914 2019-08-28Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 11 charts
NCT00952237 2018-04-25Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSFDartmouth-Hitchcock Medical CenterPhase 1 Completed13 enrolled
NCT00890552 2017-03-22A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL AmyloidosisStanford UniversityPhase NA Completed25 enrolled 12 charts
NCT00017680 2008-06-09Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain AmyloidosisOffice of Rare Diseases (ORD)Phase 2 Completed25 enrolled